Safety and utilization of blood components as therapeutic delivery systems.
about
Co-opting biology to deliver drugsCharacterization of diadzein-hemoglobin binding using optical spectroscopy and molecular dynamics simulationsProspects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.Encapsidated ultrasmall nanolipospheres as novel nanocarriers for highly hydrophobic anticancer drugs.Hydrogen bonding plays a significant role in the binding of coomassie brilliant blue-R to hemoglobin: FT-IR, fluorescence and molecular dynamics studies.Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an In Vitro study
P2860
Safety and utilization of blood components as therapeutic delivery systems.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Safety and utilization of blood components as therapeutic delivery systems.
@ast
Safety and utilization of blood components as therapeutic delivery systems.
@en
type
label
Safety and utilization of blood components as therapeutic delivery systems.
@ast
Safety and utilization of blood components as therapeutic delivery systems.
@en
prefLabel
Safety and utilization of blood components as therapeutic delivery systems.
@ast
Safety and utilization of blood components as therapeutic delivery systems.
@en
P2093
P356
P1476
Safety and utilization of blood components as therapeutic delivery systems.
@en
P2093
D Robert Lu
Fars Alanazi
Tiffany Adams
P304
P356
10.2174/1389201033489720
P577
2003-10-01T00:00:00Z